首页 > 最新文献

Surgical Case Reports最新文献

英文 中文
Failed primary repair of blunt duodenal injury managed by tube duodenostomy, gastrojejunostomy and a feeding jejunostomy: a case report. 通过管式十二指肠造口术、胃空肠造口术和进食空肠造口术处理钝性十二指肠损伤的初次修复失败:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-23 DOI: 10.1186/s40792-024-01998-4
Ngwane Ntongwetape, Elroy Patrick Weledji, Divine Martin Ngomba Mokake

Background: The worldwide increase in road traffic crashes and use of firearms has increased the incidence of duodenal injuries. Upper gastrointestinal radiological studies and computed tomography (CT) in resource settings may lead to the diagnosis of blunt duodenal injury. Exploratory laparotomy remains the ultimate diagnostic test if a high suspicion of duodenal injury continues in the face of absent or equivocal radiographic signs. Although the majority of duodenal injuries may be managed by simple repair, high-risk duodenal injuries are followed by a high incidence of suture line dehiscence and should be treated by duodenal diversion.

Case presentation: We report a case of a failed primary repair of a blunt injury to the second part of the duodenum (D2) in a 24-year-old African man. This was successfully managed by a tube duodenostomy, a bypass gastrojejunostomy and a feeding jejunostomy in a low resource setting.

Conclusions: Detailed knowledge of the available operative choices in duodenal injury and their correct application is important. When duodenal repair is needed, conservative repair techniques over complex reconstructions should be utilised. The technique of tube duodenostomy can be successfully applied to cases of large defects in the second part of the duodenum (D2), failed previous repair attempts and with defects caused by different aetiology. It may remain especially useful as a damage-control procedure in patients with multiple injuries, significant comorbidities and/or haemodynamic instability.

背景:全球范围内道路交通事故和枪支使用的增加提高了十二指肠损伤的发病率。在资源有限的情况下,上消化道放射学检查和计算机断层扫描(CT)可导致十二指肠钝伤的诊断。如果十二指肠损伤的高度怀疑仍然存在,而放射学征象缺失或不明确,那么探查性开腹手术仍然是最终的诊断测试。虽然大多数十二指肠损伤可通过简单的修复处理,但高风险十二指肠损伤后缝合线开裂的发生率很高,应通过十二指肠转流术进行治疗:我们报告了一例 24 岁非洲男子十二指肠第二段(D2)钝伤初次修复失败的病例。在资源匮乏的情况下,通过十二指肠插管造口术、旁路胃空肠造口术和进食空肠造口术成功地控制了病情:结论:详细了解十二指肠损伤的可用手术选择及其正确应用非常重要。当需要进行十二指肠修复时,应采用保守的修复技术,而不是复杂的重建技术。管状十二指肠造口术可成功应用于十二指肠第二部分(D2)的巨大缺损、之前的修复尝试失败以及不同病因导致的缺损。对于有多处损伤、严重并发症和/或血流动力学不稳定的患者,该技术作为一种损伤控制手术可能仍然特别有用。
{"title":"Failed primary repair of blunt duodenal injury managed by tube duodenostomy, gastrojejunostomy and a feeding jejunostomy: a case report.","authors":"Ngwane Ntongwetape, Elroy Patrick Weledji, Divine Martin Ngomba Mokake","doi":"10.1186/s40792-024-01998-4","DOIUrl":"10.1186/s40792-024-01998-4","url":null,"abstract":"<p><strong>Background: </strong>The worldwide increase in road traffic crashes and use of firearms has increased the incidence of duodenal injuries. Upper gastrointestinal radiological studies and computed tomography (CT) in resource settings may lead to the diagnosis of blunt duodenal injury. Exploratory laparotomy remains the ultimate diagnostic test if a high suspicion of duodenal injury continues in the face of absent or equivocal radiographic signs. Although the majority of duodenal injuries may be managed by simple repair, high-risk duodenal injuries are followed by a high incidence of suture line dehiscence and should be treated by duodenal diversion.</p><p><strong>Case presentation: </strong>We report a case of a failed primary repair of a blunt injury to the second part of the duodenum (D2) in a 24-year-old African man. This was successfully managed by a tube duodenostomy, a bypass gastrojejunostomy and a feeding jejunostomy in a low resource setting.</p><p><strong>Conclusions: </strong>Detailed knowledge of the available operative choices in duodenal injury and their correct application is important. When duodenal repair is needed, conservative repair techniques over complex reconstructions should be utilised. The technique of tube duodenostomy can be successfully applied to cases of large defects in the second part of the duodenum (D2), failed previous repair attempts and with defects caused by different aetiology. It may remain especially useful as a damage-control procedure in patients with multiple injuries, significant comorbidities and/or haemodynamic instability.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan. 一例高度怀疑术后胸壁复发的 BIA-ALCL 病例:日本报告的第三例 BIA-ALCL 病例。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-23 DOI: 10.1186/s40792-024-01996-6
Wakako Tajiri, Ryo Shimamoto, Yutaka Koga, Junji Kawasaki, Makiko Higuchi, Yoshiaki Nakamura, Yumiko Koi, Chinami Koga, Hideki Ijichi, Ilseung Choi, Youko Suehiro, Kenichi Taguchi, Eriko Tokunaga

Background: Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare malignancy. Many cases of BIA-ALCL are identified based on the presence of late-onset effusion and/or masses. Importantly, the United States Food and Drug Administration noted that in all cases diagnosed in patients with textured implants, the patients either had a history of mixed implantation of smooth and textured devices or no clinical history was supplied for review. In Japan, the first case of BIA-ALCL was reported in 2019, and we encountered the third case in Japan in December 2021. There have been a total of five cases of BIA-ALCL previously reported at Japanese academic conferences (Japan Oncoplastic Breast Surgery Society. http://jopbs.umin.jp/medical/index.html ), of which only the first case has been published. Unlike the first case, this patient had clinical features that were highly suggestive of the postoperative chest wall recurrence of breast cancer, with a mass and rash on the skin.

Case presentation: The patient was a 45-year-old woman who had undergone breast reconstruction after breast cancer surgery of the right breast 8 years previously. The patient presented with a mass and skin rash inside the inframammary area, and we suspected a damaged silicone breast implant (SBI) or chest wall recurrence. We examined the mass by a core needle biopsy and made a pathological diagnosis of BIA-ALCL. Imaging findings suggested internal thoracic lymph node swelling and lymphoma infiltration beyond the capsule but no metastatic lesions (cStage III). After en bloc resection of the SBI and lymphoma, adjuvant systemic therapy was performed.

Conclusion: We encountered the third case of BIA-ALCL in Japan. This was a case with clinically advanced stage of disease; however, the BIA-ALCL was found to be in remission.

背景:乳房植入物相关性无细胞大细胞淋巴瘤(BIA-ALCL)是一种罕见的恶性肿瘤。许多 BIA-ALCL 病例是根据晚期出现的渗出物和/或肿块而确定的。重要的是,美国食品和药物管理局注意到,在所有诊断为纹理植入物患者的病例中,患者要么有混合植入光滑和纹理植入物的病史,要么没有提供临床病史以供审查。日本于 2019 年报告了首例 BIA-ALCL 病例,我们于 2021 年 12 月在日本发现了第三例 BIA-ALCL 病例。此前在日本学术会议上(日本肿瘤乳房整形外科学会。http://jopbs.umin.jp/medical/index.html )共报道了五例 BIA-ALCL 病例,其中只有第一例已经发表。与第一例不同的是,该患者的临床特征高度提示为乳腺癌术后胸壁复发,皮肤上有肿块和皮疹:患者是一名 45 岁的女性,8 年前接受了右乳乳腺癌手术后的乳房重建。患者出现乳房下区肿块和皮疹,我们怀疑是硅胶乳房假体(SBI)受损或胸壁复发。我们对肿块进行了穿刺活检,病理诊断为 BIA-ALC。影像学检查结果显示胸腔内淋巴结肿大,淋巴瘤浸润超出囊膜,但无转移病灶(cStage III)。在对 SBI 和淋巴瘤进行全切后,进行了全身辅助治疗:结论:我们在日本发现了第三例BIA-ALCL。结论:我们在日本发现了第三例 BIA-ALCL 病例,这是一例临床晚期病例,但 BIA-ALCL 病例的病情得到了缓解。
{"title":"A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan.","authors":"Wakako Tajiri, Ryo Shimamoto, Yutaka Koga, Junji Kawasaki, Makiko Higuchi, Yoshiaki Nakamura, Yumiko Koi, Chinami Koga, Hideki Ijichi, Ilseung Choi, Youko Suehiro, Kenichi Taguchi, Eriko Tokunaga","doi":"10.1186/s40792-024-01996-6","DOIUrl":"10.1186/s40792-024-01996-6","url":null,"abstract":"<p><strong>Background: </strong>Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare malignancy. Many cases of BIA-ALCL are identified based on the presence of late-onset effusion and/or masses. Importantly, the United States Food and Drug Administration noted that in all cases diagnosed in patients with textured implants, the patients either had a history of mixed implantation of smooth and textured devices or no clinical history was supplied for review. In Japan, the first case of BIA-ALCL was reported in 2019, and we encountered the third case in Japan in December 2021. There have been a total of five cases of BIA-ALCL previously reported at Japanese academic conferences (Japan Oncoplastic Breast Surgery Society. http://jopbs.umin.jp/medical/index.html ), of which only the first case has been published. Unlike the first case, this patient had clinical features that were highly suggestive of the postoperative chest wall recurrence of breast cancer, with a mass and rash on the skin.</p><p><strong>Case presentation: </strong>The patient was a 45-year-old woman who had undergone breast reconstruction after breast cancer surgery of the right breast 8 years previously. The patient presented with a mass and skin rash inside the inframammary area, and we suspected a damaged silicone breast implant (SBI) or chest wall recurrence. We examined the mass by a core needle biopsy and made a pathological diagnosis of BIA-ALCL. Imaging findings suggested internal thoracic lymph node swelling and lymphoma infiltration beyond the capsule but no metastatic lesions (cStage III). After en bloc resection of the SBI and lymphoma, adjuvant systemic therapy was performed.</p><p><strong>Conclusion: </strong>We encountered the third case of BIA-ALCL in Japan. This was a case with clinically advanced stage of disease; however, the BIA-ALCL was found to be in remission.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical and irradiated case of early breast cancer in a patient with Ehlers-Danlos syndrome. 埃勒斯-丹洛斯综合征患者早期乳腺癌的手术和放射治疗病例。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-23 DOI: 10.1186/s40792-024-01997-5
Asumi Yamazaki, Hiroshi Tada, Yuki Muroyama, Yuto Yamazaki, Minoru Miyashita, Narumi Harada-Shoji, Yohei Hamanaka, Akiko Ebata, Miku Sato, Tokiwa Motonari, Mika Yanagaki, Tomomi Kon, Aru Sakamoto, Takashi Suzuki, Takanori Ishida

Background: Ehlers-Danlos syndrome (EDS) is a rare inherited connective tissue disease characterized by hyperextensibility of the skin and joints and tissue fragility of the skin and blood vessels, Vascular EDS is the most severe form of EDS, with abnormal arterial fragility. There have been no reports of breast cancer occurring in patients with vascular EDS. Here, we report here a very rare case of breast cancer in a patient with vascular EDS.

Case presentation: A 46-year-old woman with vascular EDS underwent partial left mastectomy and sentinel lymph node biopsy for left breast cancer (cStage 0) detected by medical examination. The final pathological diagnosis was invasive ductal carcinoma of the breast (pStage IA) [hormone receptor-positive, HER2 score 2 equivocal (FISH-positive), Ki-67LI 18%, luminal-HER2 type]. BluePrint was submitted as an aid in determining the postoperative treatment strategy, BluePrint Molecular Subtype HER2-type. However, the 10-year breast cancer mortality risk using Predict was low (5%). After consultation with the patient, the decision was made to administer postoperative radiation to the preserved breast along with hormone therapy only. There was no delay in postoperative wound healing, and the patient was free of metastatic recurrence for 9 months after surgery.

Conclusion: We performed surgery, postoperative radiotherapy, and hormonal therapy in a breast cancer patient with vascular EDS without major complications.

背景:埃勒斯-丹洛斯综合征(EDS)是一种罕见的遗传性结缔组织疾病,其特点是皮肤和关节过度伸展,皮肤和血管组织脆弱。目前还没有关于血管性 EDS 患者患乳腺癌的报道。在此,我们报告了一例非常罕见的血管性 EDS 患者患乳腺癌的病例:一名患有血管性 EDS 的 46 岁女性因体检发现左侧乳腺癌(c 阶段 0)而接受了左侧乳房部分切除术和前哨淋巴结活检。最终病理诊断为乳腺浸润性导管癌(p 阶段 IA)[激素受体阳性,HER2 评分 2 等(FISH 阳性),Ki-67LI 18%,腔隙-HER2 型]。提交 BluePrint 是为了帮助确定术后治疗策略,BluePrint 分子亚型 HER2-类型。然而,使用 Predict 预测的 10 年乳腺癌死亡风险较低(5%)。与患者协商后,决定术后只对保留的乳房进行放射治疗,同时使用激素治疗。术后伤口愈合没有延迟,患者术后 9 个月没有转移复发:我们为一名患有血管性 EDS 的乳腺癌患者实施了手术、术后放疗和激素治疗,未出现重大并发症。
{"title":"Surgical and irradiated case of early breast cancer in a patient with Ehlers-Danlos syndrome.","authors":"Asumi Yamazaki, Hiroshi Tada, Yuki Muroyama, Yuto Yamazaki, Minoru Miyashita, Narumi Harada-Shoji, Yohei Hamanaka, Akiko Ebata, Miku Sato, Tokiwa Motonari, Mika Yanagaki, Tomomi Kon, Aru Sakamoto, Takashi Suzuki, Takanori Ishida","doi":"10.1186/s40792-024-01997-5","DOIUrl":"10.1186/s40792-024-01997-5","url":null,"abstract":"<p><strong>Background: </strong>Ehlers-Danlos syndrome (EDS) is a rare inherited connective tissue disease characterized by hyperextensibility of the skin and joints and tissue fragility of the skin and blood vessels, Vascular EDS is the most severe form of EDS, with abnormal arterial fragility. There have been no reports of breast cancer occurring in patients with vascular EDS. Here, we report here a very rare case of breast cancer in a patient with vascular EDS.</p><p><strong>Case presentation: </strong>A 46-year-old woman with vascular EDS underwent partial left mastectomy and sentinel lymph node biopsy for left breast cancer (cStage 0) detected by medical examination. The final pathological diagnosis was invasive ductal carcinoma of the breast (pStage IA) [hormone receptor-positive, HER2 score 2 equivocal (FISH-positive), Ki-67LI 18%, luminal-HER2 type]. BluePrint was submitted as an aid in determining the postoperative treatment strategy, BluePrint Molecular Subtype HER2-type. However, the 10-year breast cancer mortality risk using Predict was low (5%). After consultation with the patient, the decision was made to administer postoperative radiation to the preserved breast along with hormone therapy only. There was no delay in postoperative wound healing, and the patient was free of metastatic recurrence for 9 months after surgery.</p><p><strong>Conclusion: </strong>We performed surgery, postoperative radiotherapy, and hormonal therapy in a breast cancer patient with vascular EDS without major complications.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical management of post-sublobar resection pulmonary granulomatous lesion: a report of two cases. 肺下叶切除术后肺肉芽肿病变的药物治疗:两例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-21 DOI: 10.1186/s40792-024-01969-9
Hideki Endoh, Nariaki Oura, Satoru Yanagisawa, Nobutoshi Morozumi, Nobuhiro Nishizawa, Ryohei Yamamoto, Yukitoshi Satoh

Background: Automatic stapling devices are commonly utilized in pulmonary resections, including sublobar segmentectomy. Large tumors can develop around the staple line, posing challenges in distinguishing them from cancer recurrence or inflammatory changes. In this report, we present two cases of symptomatic staple granulomatous lesion effectively managed with medications.

Case presentation: A 74-year-old man presented with a persistent cough and sputum production six years post-segmentectomy for a hamartoma in the left upper lobe. Chest computed tomography (CT) revealed a large tumor around the staple line. Laboratory investigations and bronchoscopic examination revealed no malignancy. The patient received corticosteroids and a cyclooxygenase-2 inhibitor; despite experiencing adverse reactions to steroids, both tumor size and respiratory symptoms were significantly reduced. The second case involved a 78-year-old woman who underwent pulmonary resection for suspected lung cancer. Despite a non-malignant tumor diagnosis, she reported a cough six months post-surgery. Chest CT revealed extensive shadow around the surgical staple, which was diagnosed as mycobacterium granuloma. Low-dose erythromycin induced inflammatory changes but effectively reduced the lesion.

Conclusions: Granulomatous lesions around the staple can be effectively managed with medication, and monitoring the treatment response proves valuable in distinguishing them from tumor recurrence post-pulmonary resection.

背景:自动缝合装置常用于肺切除术,包括肺叶下段切除术。缝合线周围可能出现大的肿瘤,这给区分肿瘤与癌症复发或炎症变化带来了挑战。在本报告中,我们介绍了两例症状性钉线肉芽肿病变,均通过药物治疗得到有效控制:病例介绍:一名 74 岁的男性因左上肺叶火腿肠瘤切除术后 6 年出现持续咳嗽和咳痰。胸部计算机断层扫描(CT)显示,钉线周围有一个巨大肿瘤。实验室检查和支气管镜检查均未发现恶性肿瘤。患者接受了皮质类固醇激素和环氧化酶-2抑制剂治疗;尽管类固醇出现了不良反应,但肿瘤大小和呼吸道症状都明显减轻。第二个病例涉及一名 78 岁的妇女,她因怀疑患有肺癌而接受了肺切除手术。尽管诊断为非恶性肿瘤,但她在术后六个月仍报告咳嗽。胸部 CT 发现手术缝合线周围有大量阴影,诊断为分枝杆菌肉芽肿。小剂量红霉素可诱发炎症变化,但能有效减轻病变:结论:缝合线周围的肉芽肿病变可以通过药物治疗得到有效控制,监测治疗反应对于区分肉芽肿病变和肺切除术后肿瘤复发很有价值。
{"title":"Medical management of post-sublobar resection pulmonary granulomatous lesion: a report of two cases.","authors":"Hideki Endoh, Nariaki Oura, Satoru Yanagisawa, Nobutoshi Morozumi, Nobuhiro Nishizawa, Ryohei Yamamoto, Yukitoshi Satoh","doi":"10.1186/s40792-024-01969-9","DOIUrl":"10.1186/s40792-024-01969-9","url":null,"abstract":"<p><strong>Background: </strong>Automatic stapling devices are commonly utilized in pulmonary resections, including sublobar segmentectomy. Large tumors can develop around the staple line, posing challenges in distinguishing them from cancer recurrence or inflammatory changes. In this report, we present two cases of symptomatic staple granulomatous lesion effectively managed with medications.</p><p><strong>Case presentation: </strong>A 74-year-old man presented with a persistent cough and sputum production six years post-segmentectomy for a hamartoma in the left upper lobe. Chest computed tomography (CT) revealed a large tumor around the staple line. Laboratory investigations and bronchoscopic examination revealed no malignancy. The patient received corticosteroids and a cyclooxygenase-2 inhibitor; despite experiencing adverse reactions to steroids, both tumor size and respiratory symptoms were significantly reduced. The second case involved a 78-year-old woman who underwent pulmonary resection for suspected lung cancer. Despite a non-malignant tumor diagnosis, she reported a cough six months post-surgery. Chest CT revealed extensive shadow around the surgical staple, which was diagnosed as mycobacterium granuloma. Low-dose erythromycin induced inflammatory changes but effectively reduced the lesion.</p><p><strong>Conclusions: </strong>Granulomatous lesions around the staple can be effectively managed with medication, and monitoring the treatment response proves valuable in distinguishing them from tumor recurrence post-pulmonary resection.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11335699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic resection for retroperitoneum ganglioneuroma with Supine hypotension syndrome. 腹膜后神经节瘤腹腔镜切除术伴有仰卧位低血压综合征。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-20 DOI: 10.1186/s40792-024-01992-w
Yu Sugai, Masaya Yamoto, Juma Obayashi, Takafumi Tsukui, Akiyoshi Nomura, Hiromu Miyake, Koji Fukumoto, Sung-Hae Kim, Daijiro Sato, Hideto Iwafuchi

Background: Supine hypotension syndrome (SHS) has been reported to occur due to compression by a giant tumor such as ovarian tumor. We herein report a case of retroperitoneal ganglioneuroma with SHS treated with laparoscopic resection.

Case presentation: The patient was an 11-year-old male with right-sided abdominal pain. He had a pale complexion and tachycardia while falling asleep. Computed tomography (CT) and magnetic resonance imaging (MRI) showed a giant mass lesion (60 × 35 mm) with compression of the inferior vena cava (IVC) and duodenum ventrally and the right kidney caudally. The IVC was flattened by mass compression. Abdominal ultrasonography (US) revealed narrowing of the IVC due to the mass and accelerated blood flow after IVC stenosis in the supine and left lateral recumbent position. His pale complexion and tachycardia while falling asleep was thought to be due to decreased venous return caused by the tumor compressing the IVC, resulting hypotension. 123I-MIBG scintigraphy revealed no abnormal findings. Tumor markers were normal. He was diagnosed with SHS due to a right adrenal gland tumor. The tumor compressed the IVC from the dorsal side, and hemostasis was expected to be difficult during bleeding. Therefore, a guidewire was inserted from the right femoral vein into the IVC for emergency balloon insertion during bleeding. A laparoscopic tumor resection was performed. A histopathological examination confirmed the diagnosis of primary retroperitoneal ganglioneuroma.

Conclusions: The treatment of symptomatic retroperitoneal tumors requires a multidisciplinary approach.

背景:有报道称,仰卧位低血压综合征(SHS)是由于巨大肿瘤(如卵巢肿瘤)压迫所致。我们在此报告了一例腹膜后神经节瘤伴SHS的病例,该病例采用腹腔镜切除术治疗:患者是一名11岁的男性,伴有右侧腹痛。他面色苍白,入睡时心动过速。计算机断层扫描(CT)和磁共振成像(MRI)显示出一个巨大的肿块病灶(60 × 35 毫米),腹侧压迫下腔静脉(IVC)和十二指肠,尾侧压迫右肾。下腔静脉因肿块压迫而变扁。腹部超声波检查(US)显示,肿块导致 IVC 狭窄,在仰卧位和左侧卧位时,IVC 狭窄后血流加速。他面色苍白,入睡时心动过速,被认为是由于肿瘤压迫了 IVC 导致静脉回流减少,从而引起低血压。123I-MIBG闪烁扫描未发现异常。肿瘤标志物正常。他被诊断为右肾上腺肿瘤导致的SHS。肿瘤从背侧压迫了 IVC,预计出血时止血困难。因此,从右侧股静脉插入一根导丝到 IVC,以便在出血时紧急插入球囊。患者接受了腹腔镜肿瘤切除术。组织病理学检查确诊为原发性腹膜后神经节瘤:无症状腹膜后肿瘤的治疗需要采用多学科方法。
{"title":"Laparoscopic resection for retroperitoneum ganglioneuroma with Supine hypotension syndrome.","authors":"Yu Sugai, Masaya Yamoto, Juma Obayashi, Takafumi Tsukui, Akiyoshi Nomura, Hiromu Miyake, Koji Fukumoto, Sung-Hae Kim, Daijiro Sato, Hideto Iwafuchi","doi":"10.1186/s40792-024-01992-w","DOIUrl":"10.1186/s40792-024-01992-w","url":null,"abstract":"<p><strong>Background: </strong>Supine hypotension syndrome (SHS) has been reported to occur due to compression by a giant tumor such as ovarian tumor. We herein report a case of retroperitoneal ganglioneuroma with SHS treated with laparoscopic resection.</p><p><strong>Case presentation: </strong>The patient was an 11-year-old male with right-sided abdominal pain. He had a pale complexion and tachycardia while falling asleep. Computed tomography (CT) and magnetic resonance imaging (MRI) showed a giant mass lesion (60 × 35 mm) with compression of the inferior vena cava (IVC) and duodenum ventrally and the right kidney caudally. The IVC was flattened by mass compression. Abdominal ultrasonography (US) revealed narrowing of the IVC due to the mass and accelerated blood flow after IVC stenosis in the supine and left lateral recumbent position. His pale complexion and tachycardia while falling asleep was thought to be due to decreased venous return caused by the tumor compressing the IVC, resulting hypotension. 123I-MIBG scintigraphy revealed no abnormal findings. Tumor markers were normal. He was diagnosed with SHS due to a right adrenal gland tumor. The tumor compressed the IVC from the dorsal side, and hemostasis was expected to be difficult during bleeding. Therefore, a guidewire was inserted from the right femoral vein into the IVC for emergency balloon insertion during bleeding. A laparoscopic tumor resection was performed. A histopathological examination confirmed the diagnosis of primary retroperitoneal ganglioneuroma.</p><p><strong>Conclusions: </strong>The treatment of symptomatic retroperitoneal tumors requires a multidisciplinary approach.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report. 作为甲状腺乳头状癌无性变的前兆,中性粒细胞与淋巴细胞比率和C反应蛋白随时间推移而升高:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-19 DOI: 10.1186/s40792-024-01991-x
Masaomi Sen, Ryo Ito, Takeshi Abe, Hiroko Kazusaka, Mami Matsui, Marie Saitou, Ryuta Nagaoka, Tomoo Jikuzono, Iwao Sugitani

Background: Papillary thyroid carcinoma rarely undergoes anaplastic transformation. Some risk factors for anaplastic transformation of thyroid cancer are known, but such transformation is difficult to predict in practice. We report a case demonstrating elevations of neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) over time as a precursor to anaplastic transformation of thyroid carcinoma.

Case presentation: The patient was an 89 year-old woman with a history of chronic aortic dissection. She was referred to our department after her local doctor detected thyroid nodules. She had previously been found to have multinodular goiter and enlarged left cervical lymph nodes on computed tomography. Her chief complaint was cervical discomfort and hoarseness. Blood tests revealed: white blood cells (WBCs), 4900 /µL; CRP, 0.29 mg/dL; neutrophils, 64.4%; and lymphocytes, 25.4%. A 21 mm mass was identified in the upper left lobe. Left III (16 mm) and left VI (16 mm) lymph node were enlarged on ultrasonography. Fine-needle aspiration cytology diagnosed malignant papillary carcinoma. However, due to the advanced age and medical history of the patient, a non-surgical policy was implemented. The primary tumor grew to 4 cm in diameter by 9 months after diagnosis, and blood tests showed: WBC, 7700 /µL; CRP, 0.18 mg/dL; neutrophils, 65.3%; and lymphocytes, 22.3%. By 10 months after diagnosis, the tumor had increased rapidly in diameter to 8 cm, with blood tests showing: WBC, 6500 /µL; CRP, 1.01 mg/dL; neutrophils, 68.2%; and lymphocytes, 19.3%. Anaplastic transformation of papillary thyroid carcinoma was diagnosed, and the patient was placed on treatment under a policy of best supportive care. Multiple lung metastases appeared 11 months after diagnosis, and blood test results showed: WBC, 13,300 /μL; CRP, 11.28 mg/dL; neutrophils, 93.6%; and lymphocytes, 2.3%. Unfortunately, the patient died of disease progression 63 days after identification of undifferentiated metastasis.

Conclusions: Chances to see the natural history of anaplastic transformation of thyroid cancer are rare. Elevations in NLR and CRP over time may be precursors to anaplastic transformation.

背景:甲状腺乳头状癌很少发生无性变。甲状腺癌无弹性转化的一些风险因素已为人熟知,但在实践中很难预测这种转化。我们报告了一个病例,该病例显示中性粒细胞与淋巴细胞比值(NLR)和C反应蛋白(CRP)随着时间的推移而升高,这是甲状腺癌无弹性转化的前兆:患者是一名89岁的女性,有慢性主动脉夹层病史。当地医生发现她有甲状腺结节后将她转到我科。此前,她曾被发现患有多结节性甲状腺肿,并且在计算机断层扫描中发现左颈部淋巴结肿大。她的主诉是颈椎不适和声音嘶哑。血液检查显示:白细胞(WBCs),4900 /µL;CRP,0.29 mg/dL;中性粒细胞,64.4%;淋巴细胞,25.4%。左上叶发现一个 21 毫米的肿块。超声波检查发现左III(16毫米)和左VI(16毫米)淋巴结肿大。细针穿刺细胞学诊断为恶性乳头状癌。然而,由于患者年事已高且有病史,因此采取了非手术治疗政策。原发肿瘤在确诊后 9 个月长到直径 4 厘米,血液检查显示白细胞,7700 /µL;CRP,0.18 mg/dL;中性粒细胞,65.3%;淋巴细胞,22.3%。确诊后 10 个月,肿瘤直径迅速增大到 8 厘米,血液化验结果显示白细胞:6500 /µL;CRP:1.01 mg/dL;中性粒细胞:68.2%;淋巴细胞:19.3%。确诊为甲状腺乳头状癌无性变,患者接受了最佳支持治疗。确诊后 11 个月出现多发性肺转移,血液检查结果显示:白细胞:13,300/μmol/L,淋巴细胞:19.3%:白细胞,13,300 /μL;CRP,11.28 mg/dL;中性粒细胞,93.6%;淋巴细胞,2.3%。不幸的是,患者在发现未分化转移瘤 63 天后因病情恶化死亡:结论:了解甲状腺癌无性变自然病史的机会非常罕见。随着时间的推移,NLR和CRP的升高可能是无性转化的前兆。
{"title":"Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report.","authors":"Masaomi Sen, Ryo Ito, Takeshi Abe, Hiroko Kazusaka, Mami Matsui, Marie Saitou, Ryuta Nagaoka, Tomoo Jikuzono, Iwao Sugitani","doi":"10.1186/s40792-024-01991-x","DOIUrl":"10.1186/s40792-024-01991-x","url":null,"abstract":"<p><strong>Background: </strong>Papillary thyroid carcinoma rarely undergoes anaplastic transformation. Some risk factors for anaplastic transformation of thyroid cancer are known, but such transformation is difficult to predict in practice. We report a case demonstrating elevations of neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) over time as a precursor to anaplastic transformation of thyroid carcinoma.</p><p><strong>Case presentation: </strong>The patient was an 89 year-old woman with a history of chronic aortic dissection. She was referred to our department after her local doctor detected thyroid nodules. She had previously been found to have multinodular goiter and enlarged left cervical lymph nodes on computed tomography. Her chief complaint was cervical discomfort and hoarseness. Blood tests revealed: white blood cells (WBCs), 4900 /µL; CRP, 0.29 mg/dL; neutrophils, 64.4%; and lymphocytes, 25.4%. A 21 mm mass was identified in the upper left lobe. Left III (16 mm) and left VI (16 mm) lymph node were enlarged on ultrasonography. Fine-needle aspiration cytology diagnosed malignant papillary carcinoma. However, due to the advanced age and medical history of the patient, a non-surgical policy was implemented. The primary tumor grew to 4 cm in diameter by 9 months after diagnosis, and blood tests showed: WBC, 7700 /µL; CRP, 0.18 mg/dL; neutrophils, 65.3%; and lymphocytes, 22.3%. By 10 months after diagnosis, the tumor had increased rapidly in diameter to 8 cm, with blood tests showing: WBC, 6500 /µL; CRP, 1.01 mg/dL; neutrophils, 68.2%; and lymphocytes, 19.3%. Anaplastic transformation of papillary thyroid carcinoma was diagnosed, and the patient was placed on treatment under a policy of best supportive care. Multiple lung metastases appeared 11 months after diagnosis, and blood test results showed: WBC, 13,300 /μL; CRP, 11.28 mg/dL; neutrophils, 93.6%; and lymphocytes, 2.3%. Unfortunately, the patient died of disease progression 63 days after identification of undifferentiated metastasis.</p><p><strong>Conclusions: </strong>Chances to see the natural history of anaplastic transformation of thyroid cancer are rare. Elevations in NLR and CRP over time may be precursors to anaplastic transformation.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report. 通过全基因组测序发现两名食管癌肉瘤患者的基因组改变:一份病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-19 DOI: 10.1186/s40792-024-01978-8
Masazumi Inoue, Yasuhiro Tsubosa, Sumiko Ohnami, Kazunori Tokizawa, Shuhei Mayanagi, Keiichi Ohshima, Kenichi Urakami, Shumpei Ohnami, Takeshi Nagashima, Ken Yamaguchi

Background: Esophageal carcinosarcoma (ECS) is a relatively rare malignancy, accounting for < 1% of all esophageal cancers. Its etiopathogenesis remains unknown. This study analyzed the genomic abnormalities in sarcomatous tumors from two patients undergoing subtotal esophagectomy using whole genome sequencing to elucidate the key characteristics of ECS.

Case presentation: We identified TP53 driver mutations, copy number gains in 11q13 (including CCND1), and Apolipoprotein B mRNA editing enzyme catalytic polypeptide (APOBEC) signature enrichment in both ECS patients. Along with common genetic abnormalities, we identified CDKN2A driver mutations in case 1 and RAC1, NOTCH1, and TTC28 as novel fusion gene partners of MECOM in case 2. Notably, we detected germline pathogenic variant in Fanconi anemia (FA) complementation group I (FANCI) and group G (FANCG), which are involved in repairing DNA double-strand breaks by homologous recombination, for the first time, in ECS blood samples. These germline variants were truncating-type, Lys1221fs of FANCI (rs1567179036) for case 1 and Gln365Ter of FANCG (rs121434426) for case 2. We also identified somatic changes in cancer-associated pathways, such as PI3K/Akt/mTOR, cell cycle, and NOTCH signaling pathways, and structural chromosomal defects such as chromosome doubling.

Conclusions: Our findings indicate that therapeutic drugs targeting the activation signal or FA pathway might be effective in treating ECS, however, their therapeutic significance should be elucidated in future studies.

背景:食管癌肉瘤(ECS)是一种相对罕见的恶性肿瘤,多见于病例:我们在两名食管癌患者中均发现了 TP53 驱动基因突变、11q13(包括 CCND1)拷贝数增高和载脂蛋白 B mRNA 编辑酶催化多肽(APOBEC)特征富集。除了常见的遗传异常,我们还在病例 1 中发现了 CDKN2A 驱动基因突变,在病例 2 中发现了 RAC1、NOTCH1 和 TTC28 作为 MECOM 的新型融合基因伙伴。值得注意的是,我们首次在 ECS 血液样本中检测到范可尼贫血(FA)补体 I 组(FANCI)和 G 组(FANCG)的种系致病变体,这些变体通过同源重组参与 DNA 双链断裂的修复。这些种系变异是截断型的,病例 1 是 FANCI 的 Lys1221fs(rs1567179036),病例 2 是 FANCG 的 Gln365Ter(rs121434426)。我们还发现了癌症相关通路(如 PI3K/Akt/mTOR、细胞周期和 NOTCH 信号通路)的体细胞变化,以及染色体结构缺陷(如染色体加倍):我们的研究结果表明,针对激活信号或FA通路的治疗药物可能对治疗ECS有效,但其治疗意义还需在今后的研究中进一步阐明。
{"title":"Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report.","authors":"Masazumi Inoue, Yasuhiro Tsubosa, Sumiko Ohnami, Kazunori Tokizawa, Shuhei Mayanagi, Keiichi Ohshima, Kenichi Urakami, Shumpei Ohnami, Takeshi Nagashima, Ken Yamaguchi","doi":"10.1186/s40792-024-01978-8","DOIUrl":"10.1186/s40792-024-01978-8","url":null,"abstract":"<p><strong>Background: </strong>Esophageal carcinosarcoma (ECS) is a relatively rare malignancy, accounting for < 1% of all esophageal cancers. Its etiopathogenesis remains unknown. This study analyzed the genomic abnormalities in sarcomatous tumors from two patients undergoing subtotal esophagectomy using whole genome sequencing to elucidate the key characteristics of ECS.</p><p><strong>Case presentation: </strong>We identified TP53 driver mutations, copy number gains in 11q13 (including CCND1), and Apolipoprotein B mRNA editing enzyme catalytic polypeptide (APOBEC) signature enrichment in both ECS patients. Along with common genetic abnormalities, we identified CDKN2A driver mutations in case 1 and RAC1, NOTCH1, and TTC28 as novel fusion gene partners of MECOM in case 2. Notably, we detected germline pathogenic variant in Fanconi anemia (FA) complementation group I (FANCI) and group G (FANCG), which are involved in repairing DNA double-strand breaks by homologous recombination, for the first time, in ECS blood samples. These germline variants were truncating-type, Lys1221fs of FANCI (rs1567179036) for case 1 and Gln365Ter of FANCG (rs121434426) for case 2. We also identified somatic changes in cancer-associated pathways, such as PI3K/Akt/mTOR, cell cycle, and NOTCH signaling pathways, and structural chromosomal defects such as chromosome doubling.</p><p><strong>Conclusions: </strong>Our findings indicate that therapeutic drugs targeting the activation signal or FA pathway might be effective in treating ECS, however, their therapeutic significance should be elucidated in future studies.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous mesenteric hematoma occurring during antithrombotic therapy and responsive to surgical treatment: a case report. 抗血栓治疗期间出现自发性肠系膜血肿并对手术治疗有反应:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-16 DOI: 10.1186/s40792-024-01993-9
Meiko Aoki, Hisamichi Yoshii, Rika Fujino, Hideki Izumi, Masaya Mukai, Hiroyasu Makuuchi

Background: Spontaneous mesenteric hematoma is a rare condition that is diagnosed when clinical and pathological findings do not identify an obvious causative disease. Various treatment options for spontaneous mesenteric hematoma exist; however, there are no clear treatment criteria. Herein, we report a case of spontaneous mesenteric hematoma that was successfully treated surgically and discuss the optimum treatment strategy based on similar cases.

Case presentation: A 63-year-old man with abdominal persisting for 3 days presented to our hospital after going into shock without any triggers. The patient had a history of atrial fibrillation, stroke, and an aneurysm, and was receiving antithrombotic therapy. Abdominal contrast-enhanced computed tomography revealed a mass structure within the sigmoid mesentery, which was suspected to be a hematoma. The patient was admitted to the hospital for follow-up observation after initial infusion and vital stabilization. However, the following day, the patient developed acute generalized peritonitis with necrosis of the sigmoid colon; therefore, emergency Hartmann's surgery was performed. Intraoperative and histopathological examinations revealed no evidence of bleeding.

Conclusion: Spontaneous mesenteric hematomas tend to be associated with intestinal necrosis and may require surgical treatment with bowel resection owing to the difficulty in identifying the responsible vessel. Moreover, our results suggest that the presence of antithrombotic therapy may be an important factor affecting spontaneous mesenteric hematoma development.

背景:自发性肠系膜血肿是一种罕见病,当临床和病理检查结果无法确定明显的致病疾病时即可诊断为自发性肠系膜血肿。自发性肠系膜血肿有多种治疗方案,但没有明确的治疗标准。在此,我们报告了一例成功通过手术治疗的自发性肠系膜血肿病例,并根据类似病例讨论了最佳治疗策略:一名 63 岁的男性患者,腹部持续疼痛 3 天,在没有任何诱因的情况下出现休克,随后到我院就诊。患者有心房颤动、中风和动脉瘤病史,正在接受抗血栓治疗。腹部造影剂增强计算机断层扫描显示乙状结肠系膜内有肿块结构,怀疑是血肿。在初步输液和生命体征稳定后,患者入院进行后续观察。但第二天,患者出现急性全身腹膜炎,乙状结肠坏死,因此紧急进行了哈特曼手术。术中和组织病理学检查均未发现出血迹象:结论:自发性肠系膜血肿往往伴有肠坏死,由于难以确定责任血管,可能需要进行肠切除手术治疗。此外,我们的研究结果表明,抗血栓治疗的存在可能是影响自发性肠系膜血肿发生的一个重要因素。
{"title":"Spontaneous mesenteric hematoma occurring during antithrombotic therapy and responsive to surgical treatment: a case report.","authors":"Meiko Aoki, Hisamichi Yoshii, Rika Fujino, Hideki Izumi, Masaya Mukai, Hiroyasu Makuuchi","doi":"10.1186/s40792-024-01993-9","DOIUrl":"10.1186/s40792-024-01993-9","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous mesenteric hematoma is a rare condition that is diagnosed when clinical and pathological findings do not identify an obvious causative disease. Various treatment options for spontaneous mesenteric hematoma exist; however, there are no clear treatment criteria. Herein, we report a case of spontaneous mesenteric hematoma that was successfully treated surgically and discuss the optimum treatment strategy based on similar cases.</p><p><strong>Case presentation: </strong>A 63-year-old man with abdominal persisting for 3 days presented to our hospital after going into shock without any triggers. The patient had a history of atrial fibrillation, stroke, and an aneurysm, and was receiving antithrombotic therapy. Abdominal contrast-enhanced computed tomography revealed a mass structure within the sigmoid mesentery, which was suspected to be a hematoma. The patient was admitted to the hospital for follow-up observation after initial infusion and vital stabilization. However, the following day, the patient developed acute generalized peritonitis with necrosis of the sigmoid colon; therefore, emergency Hartmann's surgery was performed. Intraoperative and histopathological examinations revealed no evidence of bleeding.</p><p><strong>Conclusion: </strong>Spontaneous mesenteric hematomas tend to be associated with intestinal necrosis and may require surgical treatment with bowel resection owing to the difficulty in identifying the responsible vessel. Moreover, our results suggest that the presence of antithrombotic therapy may be an important factor affecting spontaneous mesenteric hematoma development.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report. 使用吉西他滨和纳布紫杉醇对无法切除的胰腺腺鳞癌进行转换意向化疗后成功实施胰腺切除术:病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-16 DOI: 10.1186/s40792-024-01989-5
Kenichi Nakamura, Mitsuru Nakagawa, Mizuki Ariga, Takahiko Higashiguchi, Yuko Chikaishi, Kazuhiro Matsuo, Aki Nishijima, Tomoyoshi Endo, Kenji Kikuchi, Koji Morohara, Hidetoshi Katsuno, Yoshihiko Tachi, Ichiro Uyama, Koichi Suda, Zenichi Morise

Background: Adenosquamous carcinoma of the pancreas (ASCP) accounts for only 1-4% of all pancreatic exocrine cancers and has a particularly poor prognosis. The efficacy of chemotherapy for ASCP remains unknown because of the small number of cases, and few studies have evaluated conversion-intended chemotherapy.

Case presentation: A 76-year-old woman was referred to our hospital because of epigastric pain and nausea. A preoperative contrast-enhanced multidetector row computed tomography (MDCT) scan revealed a 17 × 17 mm low-density tumor with an ill-defined margin at the arterial phase in the pancreatic head. The tumor involved the common hepatic artery, left hepatic artery bifurcated from the common hepatic artery, and gastroduodenal artery, and was in contact with the portal vein. Fluorodeoxyglucose-positron emission tomography (FDG-PET) showed an uptake in the pancreatic head but no evidence of distant metastasis. The tumor was diagnosed as an adenocarcinoma of the pancreatic head and staged unresectable because the common and left hepatic arteries were involved. Hence, the patient underwent seven courses of conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for pancreatic ductal adenocarcinoma over 7 months. After chemotherapy, the tumor shrank to 10 × 10 mm on contrast-enhanced MDCT. Consequently, the boundary between the tumor and major vessels of the common and left hepatic arteries and the portal vein became clear, and the involvement of the arteries with the tumor was evaluated to be released. The contact of the tumor to the portal vein also reduced to less than half the circumference of the portal vein. FDG-PET showed decreased accumulation in the tumor. Hence, the tumor was judged resectable, and pancreaticoduodenectomy was performed. The tumor and major blood vessels were easily dissected and R0 resection was achieved. The patient experienced no major complications and was discharged on postoperative day 28. The tumor was revealed as ASCP via pathological examination. The patient is alive and recurrence-free seven months after surgery. This is the first report of successful R0 resection for an initially unresectable ASCP following conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen.

Conclusions: Conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen may be effective for ASCP.

背景:胰腺腺鳞癌(ASCP)仅占所有胰腺外分泌癌的1-4%,预后特别差。由于ASCP的病例较少,化疗的疗效仍是未知数,很少有研究对转化意向化疗进行评估:一名 76 岁的妇女因上腹疼痛和恶心转诊至我院。术前造影剂增强多载体行计算机断层扫描(MDCT)显示,胰腺头部有一个 17 × 17 毫米的低密度肿瘤,动脉期边缘不清。肿瘤累及肝总动脉、肝总动脉分叉的左肝动脉和胃十二指肠动脉,并与门静脉相通。氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)显示胰腺头部有摄取,但没有远处转移的迹象。肿瘤被诊断为胰头腺癌,由于累及肝总动脉和左肝动脉,因此无法切除。因此,患者在7个月内接受了7个疗程的吉西他滨和纳布-紫杉醇治疗胰腺导管腺癌的转换意向化疗。化疗后,造影剂增强 MDCT 显示肿瘤缩小至 10 × 10 毫米。因此,肿瘤与肝总动脉、左肝动脉和门静脉等主要血管之间的边界变得清晰,动脉与肿瘤的累及关系被评估为释放。肿瘤与门静脉的接触也缩小到门静脉周径的一半以下。FDG-PET 显示肿瘤内积聚减少。因此,判断肿瘤可以切除,并进行了胰十二指肠切除术。肿瘤和主要血管很容易剥离,实现了 R0 切除。患者没有出现重大并发症,术后第 28 天出院。病理检查显示肿瘤为 ASCP。患者术后 7 个月仍存活且无复发。这是首次报道使用吉西他滨和纳布-紫杉醇方案进行转换意向化疗后,成功对最初无法切除的ASCP进行R0切除:结论:使用吉西他滨和纳布紫杉醇方案进行转化预期化疗可能对ASCP有效。
{"title":"Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report.","authors":"Kenichi Nakamura, Mitsuru Nakagawa, Mizuki Ariga, Takahiko Higashiguchi, Yuko Chikaishi, Kazuhiro Matsuo, Aki Nishijima, Tomoyoshi Endo, Kenji Kikuchi, Koji Morohara, Hidetoshi Katsuno, Yoshihiko Tachi, Ichiro Uyama, Koichi Suda, Zenichi Morise","doi":"10.1186/s40792-024-01989-5","DOIUrl":"10.1186/s40792-024-01989-5","url":null,"abstract":"<p><strong>Background: </strong>Adenosquamous carcinoma of the pancreas (ASCP) accounts for only 1-4% of all pancreatic exocrine cancers and has a particularly poor prognosis. The efficacy of chemotherapy for ASCP remains unknown because of the small number of cases, and few studies have evaluated conversion-intended chemotherapy.</p><p><strong>Case presentation: </strong>A 76-year-old woman was referred to our hospital because of epigastric pain and nausea. A preoperative contrast-enhanced multidetector row computed tomography (MDCT) scan revealed a 17 × 17 mm low-density tumor with an ill-defined margin at the arterial phase in the pancreatic head. The tumor involved the common hepatic artery, left hepatic artery bifurcated from the common hepatic artery, and gastroduodenal artery, and was in contact with the portal vein. Fluorodeoxyglucose-positron emission tomography (FDG-PET) showed an uptake in the pancreatic head but no evidence of distant metastasis. The tumor was diagnosed as an adenocarcinoma of the pancreatic head and staged unresectable because the common and left hepatic arteries were involved. Hence, the patient underwent seven courses of conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for pancreatic ductal adenocarcinoma over 7 months. After chemotherapy, the tumor shrank to 10 × 10 mm on contrast-enhanced MDCT. Consequently, the boundary between the tumor and major vessels of the common and left hepatic arteries and the portal vein became clear, and the involvement of the arteries with the tumor was evaluated to be released. The contact of the tumor to the portal vein also reduced to less than half the circumference of the portal vein. FDG-PET showed decreased accumulation in the tumor. Hence, the tumor was judged resectable, and pancreaticoduodenectomy was performed. The tumor and major blood vessels were easily dissected and R0 resection was achieved. The patient experienced no major complications and was discharged on postoperative day 28. The tumor was revealed as ASCP via pathological examination. The patient is alive and recurrence-free seven months after surgery. This is the first report of successful R0 resection for an initially unresectable ASCP following conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen.</p><p><strong>Conclusions: </strong>Conversion-intended chemotherapy using gemcitabine and nab-paclitaxel regimen may be effective for ASCP.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right upper lobectomy for lung cancer associated with a displaced anomalous bronchus: two case reports. 伴有移位异常支气管的肺癌右上叶切除术:两份病例报告。
IF 0.7 Q4 SURGERY Pub Date : 2024-08-15 DOI: 10.1186/s40792-024-01986-8
Yoshihito Iijima, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Nozomu Motono, Hidetaka Uramoto

Background: Bronchial bifurcation abnormalities are often discovered incidentally on chest computed tomography or bronchoscopy. As this condition is asymptomatic, it has little effect on the disease course of patients with lung cancer. However, this abnormality must be considered when performing lung resection.

Case presentation: Patient 1 was a 73-year-old man with suspected simultaneous triple lung cancers [cT1c (3) N0M0, Stage IA3] in the right and left upper lobes. He was initially scheduled to undergo right upper lobectomy and systematic nodal dissection. Chest computed tomography revealed a displaced B3 that arose from the right middle lobe bronchus. V1+2 was transected first, followed by the superior truncus of the pulmonary artery, and B1+2, respectively. After the branches of V3 were ligated, B3 was identified smoothly. Finally, the incomplete interlobar fissure between the upper and middle lobes was separated using an auto-stapler. No vascular abnormalities were observed. Patient 2 was a 62-year-old woman with suspected lung cancer (cT1cN0M0, Stage IA3) in the right upper lobe, and was scheduled to undergo right upper lobectomy and lobe-specific nodal dissection. Chest computed tomography revealed a right top pulmonary vein and a displaced B1 that arose from the right main bronchus independently. Because V1+3 was resected simultaneously during upper and middle lobe resection during robot-assisted thoracic surgery, the procedure was cool-converted to video-assisted thoracic surgery. An independently A1 was observed, followed by A2b and A3, which branched off as a common stem. A right top pulmonary vein was smoothly detected. Each blood vessel was transected using an auto-stapler. B2+3 was transected first using an auto-stapler, followed by B1.

Conclusions: The displaced anomalous bronchus is often accompanied by pulmonary arterial or venous abnormalities and an incomplete interlobar fissure. A "hilum first, fissure last" technique is often useful. Preoperative evaluation and surgical planning are important.

背景:支气管分叉异常通常是在胸部计算机断层扫描或支气管镜检查中偶然发现的。由于这种情况没有症状,因此对肺癌患者的病程影响不大。然而,在进行肺切除术时必须考虑到这种异常情况:患者 1 是一名 73 岁的男性,左右上叶疑似同时患有三肺癌[cT1c (3) N0M0,IA3 期]。他原定接受右上肺叶切除术和系统性结节切除术。胸部计算机断层扫描显示,从右中叶支气管移位的B3。首先横断了 V1+2,然后分别横断了肺动脉上干和 B1+2。结扎 V3 的分支后,顺利找到 B3。最后,使用自动缝合器分离上叶和中叶之间不完整的叶间裂。未观察到血管异常。患者 2 是一名 62 岁的女性,右肺上叶疑似肺癌(cT1cN0M0,IA3 期),计划接受右肺上叶切除术和肺叶特异性结节切除术。胸部计算机断层扫描显示右上肺静脉和从右主支气管独立产生的移位 B1。由于在机器人辅助胸腔手术中切除上叶和中叶时同时切除了V1+3,因此手术被冷转为视频辅助胸腔手术。观察到一个独立的 A1,随后是 A2b 和 A3,它们作为一个共同的干分支。顺利检测到右上肺静脉。使用自动横切器横切每条血管。首先使用自动剥离器横切 B2+3,然后横切 B1:结论:移位的异常支气管通常伴有肺动脉或静脉异常以及不完整的叶间裂。因此,采用 "先切颈部,后切裂隙 "的技术通常很有用。术前评估和手术规划非常重要。
{"title":"Right upper lobectomy for lung cancer associated with a displaced anomalous bronchus: two case reports.","authors":"Yoshihito Iijima, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Nozomu Motono, Hidetaka Uramoto","doi":"10.1186/s40792-024-01986-8","DOIUrl":"10.1186/s40792-024-01986-8","url":null,"abstract":"<p><strong>Background: </strong>Bronchial bifurcation abnormalities are often discovered incidentally on chest computed tomography or bronchoscopy. As this condition is asymptomatic, it has little effect on the disease course of patients with lung cancer. However, this abnormality must be considered when performing lung resection.</p><p><strong>Case presentation: </strong>Patient 1 was a 73-year-old man with suspected simultaneous triple lung cancers [cT1c (3) N0M0, Stage IA3] in the right and left upper lobes. He was initially scheduled to undergo right upper lobectomy and systematic nodal dissection. Chest computed tomography revealed a displaced B<sup>3</sup> that arose from the right middle lobe bronchus. V<sup>1+2</sup> was transected first, followed by the superior truncus of the pulmonary artery, and B<sup>1+2</sup>, respectively. After the branches of V<sup>3</sup> were ligated, B<sup>3</sup> was identified smoothly. Finally, the incomplete interlobar fissure between the upper and middle lobes was separated using an auto-stapler. No vascular abnormalities were observed. Patient 2 was a 62-year-old woman with suspected lung cancer (cT1cN0M0, Stage IA3) in the right upper lobe, and was scheduled to undergo right upper lobectomy and lobe-specific nodal dissection. Chest computed tomography revealed a right top pulmonary vein and a displaced B<sup>1</sup> that arose from the right main bronchus independently. Because V<sup>1+3</sup> was resected simultaneously during upper and middle lobe resection during robot-assisted thoracic surgery, the procedure was cool-converted to video-assisted thoracic surgery. An independently A<sup>1</sup> was observed, followed by A<sup>2</sup><sub>b</sub> and A<sup>3</sup>, which branched off as a common stem. A right top pulmonary vein was smoothly detected. Each blood vessel was transected using an auto-stapler. B<sup>2+3</sup> was transected first using an auto-stapler, followed by B<sup>1</sup>.</p><p><strong>Conclusions: </strong>The displaced anomalous bronchus is often accompanied by pulmonary arterial or venous abnormalities and an incomplete interlobar fissure. A \"hilum first, fissure last\" technique is often useful. Preoperative evaluation and surgical planning are important.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11324617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgical Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1